Serum titin/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophies.

Nambu Y, Osawa K, Shirakawa T, Sunami A, Sonehara S, Bo R, Nozu K, Matsuo M, Awano H

Open source

DOI
10.3389/fneur.2025.1591748
Published
2025
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2025.1591748,
  title = {Serum titin/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophies.},
  author = {Nambu Y and Osawa K and Shirakawa T and Sunami A and Sonehara S and Bo R and Nozu K and Matsuo M and Awano H},
  year = {2025},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2025.1591748},
  url = {https://doi.org/10.3389/fneur.2025.1591748}
}

RIS

TY  - JOUR
TI  - Serum titin/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophies.
AU  - Nambu Y
AU  - Osawa K
AU  - Shirakawa T
AU  - Sunami A
AU  - Sonehara S
AU  - Bo R
AU  - Nozu K
AU  - Matsuo M
AU  - Awano H
PY  - 2025
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2025.1591748
UR  - https://doi.org/10.3389/fneur.2025.1591748
ER  - 

APA

Y, N., K, O., T, S., A, S., S, S., R, B., K, N., M, M., & H, A. (2025). Serum titin/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophies.. Frontiers in neurology. https://doi.org/10.3389/fneur.2025.1591748

Source records